Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
EP PerMed organises an JTC2026 Information Day introducing the JTC2026 to the research community on 16 December 2025.
The EP PerMed Joint Transnational Call 2026 (JTC2026) “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases” (acronym: CARMEN2026), co-funded by the European Union, will fund multinational, innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe and beyond in this field. The JTC2026 will be conducted simultaneously by the participating funding organisations in their respective region/country.
The call will be implemented in two stages, i.e. a pre- and a full proposal phase. The available budget for this call is 38 Mio. € (approx.).
Agenda
| Time | Topic |
|---|---|
| 10:00 – 10:05 | Dial-in |
| 10:05 – 10:20 | Welcome by the EP PerMed Coordinator EP PerMed coordinator team |
| 10:20 – 11:20 | Introduction in the JTC2026 CARMEN2026 ISCIII, Joint Call Secretariat |
| 11:50 – 12:00 | General Questions and Answers |
Registration
Registration for the Call Information Day will open soon.